Pinpoint's CEO Lisa Diamond has a 40-year track record of technology innovation and senior engineering management, from pioneering development in molecular diagnostics and computational genomics to financial and trading applications, business intelligence and analytics, computer animation, digital video, and more.
She has collaborated with Dr. Pourmand over the last twelve years to develop novel molecular diagnostics for pathogens including pandemic influenza, human papilloma virus, and drug-resistant TB, and holds two patents for novel molecular diagnostics.
Diamond is also principal software and systems architect with San Francisco non-profit Global Viral. As systems architect and developer at the Stanford Genome Technology Center for ten years, she built software to generate molecular probes for colon and esophageal cancer, pandemic influenza, drug-resistant TB, and human papilloma virus, and developed novel software to analyze the vaginal microbiome. Other software innovation at startup Pathogenica focused on panels of multiplexed probes to identify pathogens and characterize resistance and virulence.
As VP of Engineering at Black Pearl, she led the development of innovative AI business applications. Lisa led streaming wireless and data visualization development for equity trading as VP of Technology Innovation at Reuters and led the Market Data Engineering team at their Tibco Finance Technology division in Palo Alto.
Prior to that, as vice president of Architecture and Strategy for Global Market Data Systems at Merrill Lynch, she was responsible for key trading floor infrastructure and applications in Tokyo and New York. Earlier in her career, Lisa pioneered groundbreaking real-time graphics, animation, and digital video systems.